Spineology has received US Food and Drug Administration (FDA ) clearance for its new Rampart line of Interbody fusion implants.
The interbody fusion system is incorporated with implantation equipment designed to enhance a surgeon’s ability to position the implant within the disc space.
Go deeper with GlobalData
The Rampart line will feature a variety of implant configurations, lengths and heights providing the surgeon with several options to fit patient needs.
The company is committed to increasing procedural efficiency, reducing surgical morbidity and accelerating patient recovery.
GlobalData Strategic Intelligence
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
